DS
EBACU

David Shaw’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

David Shaw’s Portfolio EBACU Stock Details EBACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-68,721
Closed -$686K – 5420
2021
Q2 		$686K Buy
68,721
+35,388
+106% +$354K ﹤0.01% 3846
2021
Q1 		$335K Buy
+33,333
New +$333K ﹤0.01% 3666

Other funds holding EBACU

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return

David Shaw's EBACU Position: Q3 2021 in Review

David Shaw sold out of European Biotech Acquisition Corp. Units (EBACU) in Q3 2021, closing a stake of 68,721 shares — an estimated $686K sold.

David Shaw first reported a position in EBACU in Q1 2021 and held it in 2 quarters. The position peaked at $686K in Q2 2021. 30 funds tracked by Wall St. Rank hold EBACU as of Q3 2021.

  • David Shaw reported no remaining European Biotech Acquisition Corp. Units position as of Q3 2021 after selling out during the quarter.
  • David Shaw sold 68,721 European Biotech Acquisition Corp. Units shares in Q3 2021, an estimated $686K.
  • David Shaw first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 2 quarters.
  • David Shaw's European Biotech Acquisition Corp. Units position peaked at $686K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.